Centene Cash Flow Statement
NYSE: CNCHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Centene free cash flow
In fiscal 2025, Centene generated $5.09 billion of operating cash flow and spent $767.0 million on capital expenditures. That left free cash flow of $4.32 billion, a free-cash-flow margin of 2.2% of revenue. Centene returned $475.0 million to shareholders through share repurchases, equal to 11% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Centene cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -6.68B | 3.29B | 2.70B | 1.20B | 1.34B | 1.79B | 1.31B | 894.00M | 808.00M | 561.00M |
| Net Income growth (YoY) | -302.70% | +22.05% | +124.54% | -10.03% | -25.53% | +37.05% | +46.42% | +10.64% | +44.03% | +57.14% |
| Depreciation & Amortization | 1.27B | 1.24B | 1.29B | 1.43B | 1.33B | 1.26B | 643.00M | 495.00M | 361.00M | 278.00M |
| Stock-Based Compensation | 204.00M | 212.00M | 216.00M | 234.00M | 203.00M | 281.00M | 177.00M | 145.00M | 135.00M | 148.00M |
| Change in Working Capital | -807.00M | -536.00M | 3.64B | 580.00M | 933.00M | 27.00M | -664.00M | -623.00M | -74.00M | 612.00M |
| Operating Cash Flow | 5.09B | 154.00M | 8.05B | 6.26B | 4.21B | 5.50B | 1.48B | 1.23B | 1.49B | 1.85B |
| Capital Expenditures | -767.00M | -644.00M | -799.00M | -1.00B | -910.00M | -869.00M | -730.00M | -675.00M | -422.00M | -306.00M |
| Investing Cash Flow | 472.00M | -1.05B | -1.19B | -2.92B | -3.30B | -6.96B | -1.53B | -4.58B | -1.25B | -2.47B |
| Share Repurchases | -475.00M | -3.12B | -1.63B | -3.10B | -297.00M | -626.00M | -75.00M | -71.00M | -65.00M | -63.00M |
| Debt Issued | 750.00M | 1.30B | 2.33B | 360.00M | 9.27B | 5.11B | 24.72B | 6.08B | 1.40B | 8.95B |
| Debt Repaid | -1.90B | -622.00M | -2.32B | -1.49B | -7.43B | -4.07B | -17.80B | -4.08B | -1.35B | -6.08B |
| Financing Cash Flow | -1.62B | -2.41B | -1.66B | -4.20B | 1.36B | 260.00M | 6.83B | 4.61B | -82.00M | 2.72B |
| Net Change in Cash | 3.94B | -3.30B | 5.17B | -868.00M | 2.26B | -1.17B | 6.78B | 1.26B | 153.00M | 2.10B |
| Free Cash Flow | 4.32B | -490.00M | 7.25B | 5.26B | 3.29B | 4.63B | 753.00M | 559.00M | 1.07B | 1.54B |
This table shows 10 annual periods of Centene's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CNC's reporting calendar. What is a cash flow statement?